Brief: NLS Pharmaceutics On Aug 28, Agreed With Eurofarma Laboriatorios S.A. To Terminate EF License Agreement Dated Feb 2019, Effective Sept 30
13/09/2024 23:04
Sept 13 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS: ON AUG 28, AGREED WITH EUROFARMA
LABORIATORIOS S.A. TO TERMINATE EF LICENSE AGREEMENT DATED FEB
2019, EFFECTIVE SEPT 30
Source text for Eikon: ID:n0001213900-24-078645
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing